claim
Navitoclax has shown effectiveness when combined with various therapy-induced senescence (TIS) methods, including ionizing radiation, rituximab (CD20 antibody), doxorubicin, paclitaxel, docetaxel, or gemcitabine.

Authors

Sources

Referenced by nodes (1)